+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-09-01Number of Pages: 98

Postpartum Hemorrhage (PPH) Treatment Devices Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023

The escalating cases of maternal deaths have fuelled demand for advanced therapeutics and devices to ensure effective treatment for pregnancy related complications. Spurred by the factor, demand from the postpartum hemorrhage (PPH) treatment devices market is expected to increase considerably. While manufacturers of these devices have found lucrative prospects in developed nations, they are yet to establish their presence across developing and under developed countries.

According to Transparency Market Research (TMR), lack of awareness creates bottlenecks for entry of PPH treatment device manufacturers in nations across the Middle East, Asia Pacific, and sub-Saharan Africa. Nevertheless, with governments and leading organizations focusing on spreading awareness about PPH treatment, proliferation of PPH devices is expected to pace up in the forthcoming years.

TMR forecasts the global PPH treatment market to exhibit a CAGR of 4.9% between 2015 and 2021. The market stood at US$604.4 mn in 2014 and is expected to reach US$926.1 mn by the end of 2023.

Demand for Uniject Prefilled Injection Systems to Rise at Higher Pace than other Product Segments

Among the various products available, the market is currently witnessing considerably high demand for uterine balloon tamponade. It is commercially available, offers high effectiveness, and ensures ease of use. Balloon tamponade thus emerged as the dominant product segment in the market in 2014. It is expected to rise at a CAGR of 4.9% between 2015 and 2023.

However, according to TMR, demand for uniject prefilled injection systems is likely to increase at a higher pace than other products available in the market. Uniject is an auto-disable and disposable injection system. The product segment is expected to witness considerably rising demand through the forecast period due to the easy applicability of uniject prefilled injection systems, their equitable pricing, and rising participation by government organizations in promoting their use.

Besides this, TMR also projects the application of non-pneumatic anti-shock garment (NASG) to increase significantly in the near future.

Commercial Availability of Advanced Devices Confirms North America’s Lead in Global PPH Treatment Devices Market

Regionally, the global PPH treatment devices market is currently dominated by North America. The region held over 36.1% of the global market in 2014. The rising prevalence of PPH in North America, increasing awareness among patients as well as healthcare service providers, high hospital delivery rates, and commercial availability of treatment devices are the primary factors fuelling demand from the North America treatment devices market. Manufacturers of PPH treatment devices have been witnessing lucrative opportunities in countries such as the U.S., Canada, and Mexico. These countries boast sophisticated healthcare infrastructure, which aids the expansion of the PPH treatment devices market in the region.

Europe trailed North America in terms of revenue contributed to the global PPH treatment devices market in 2014. However, during the course of the forecast period, demand from Asia Pacific is expected to rise at a higher pace. The improving healthcare infrastructure will fuel demand for PPH treatment devices in countries such as India, China, Philippines, and Taiwan. Furthermore, programs initiated by governments to prevent maternal deaths will also boost sales opportunities for manufacturers across these countries.

Some of the key players in the global postpartum hemorrhage treatment devices market are Bactiguard, Cook Medical, C.R. Bard, Utah Medical Products, Teleflex Incorporated, and Program for Appropriate Technology in Health (PATH).

 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Postpartum Hemorrhage Treatment Devices Market (2014 and 2023)
2.2 Comparative Analysis: Global Postpartum Hemorrhage Treatment Devices Market, by Geography, 2014 & 2023 (Value %)
 
Chapter 3 Global Postpartum Hemorrhage Treatment Devices Market Overview
3.1 Market Dynamics and Overview
3.2 Market Drivers
      3.2.1 High Prevalence of PPH Expected to Drive Market Growth
      3.2.2 Increasing Government Educational Initiatives and Training Likely to Support Growth of the PPH Treatment Devices Market
      3.2.3 Escalating Risk Factors Associated With PPH is Expected to Fuel the Market Growth
3.3 Market Restraints
      3.3.1 Lack of Product Awareness in Untapped Markets
      3.3.2 Low Acceptance of Unconventional Postpartum Hemorrhage Preventive Devices
3.4 Market Opportunities
      3.4.1 Focus on Enhancing Distribution Channels and Awareness in Emerging Markets
3.5 Porter’s Five Forces Analysis: Global Postpartum Hemorrhage Treatment Devices Market
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of Substitutes
      3.5.4 Threat of New Entrants
      3.5.5 Competitive Rivalry
3.6 Event Impact Assessment: Global Postpartum Hemorrhage Treatment Devices Market
3.7 Heat Map Analysis for Global Postpartum Hemorrhage Treatment Devices Market, by Key Market Players and Regional Presence
3.8 Regulatory Framework: Global Postpartum Hemorrhage Treatment Devices Market
3.9 Global Percentages of Women with PPH Treated with Different Interventions
3.10 Market Attractiveness Analysis: Global Postpartum Hemorrhage Treatment Devices Market, by Geography
 
Chapter 4 Global Postpartum Hemorrhage Treatment Devices Market, by Product Type
4.1 Overview
      4.1.1 Global Postpartum Hemorrhage Treatment Devices Market Revenue, by Product Type, 2013–2023 (USD Million)
4.2 Non-pneumatic Anti-shock Garment (NASG)
      4.2.1 Global NASG Market Revenue for Postpartum Hemorrhage Treatment, 2013–2023 (USD Million)
4.3 Uniject Prefilled Injection System
      4.3.1 Global Uniject Prefilled Injection System Market Revenue for Postpartum Hemorrhage Treatment, 2013–2023 (USD Million)
4.4 Uterine Balloon Tamponade
      4.4.1 Global Uterine Balloon Tamponade Market Revenue, by Product Type, 2013–2023 (USD Million)
      4.4.2 Foley Catheters
              4.4.2.1 Global Foley Catheters Market Revenue, 2013–2023 (USD Million)
      4.4.3 Condom Catheters
              4.4.3.1 Global Condom Catheters Market Revenue, 2013–2023 (USD Million)
      4.4.4 Others
              4.4.4.1 Global Other Tamponades Market Revenue, 2013–2023 (USD Million)
 
Chapter 5 Global Postpartum Hemorrhage Treatment Devices Market, By Geography
5.1 Overview
      5.1.1 Global Postpartum Hemorrhage Treatment Devices Market Revenue, by Geography, 2013–2023 (USD Million)
5.2 North America
      5.2.1 North America Postpartum Hemorrhage Treatment Devices Market Revenue, by Country, 2013–2023 (USD Million)
      5.2.2 U.S.
              5.2.2.1 U.S. Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
      5.2.3 Canada
              5.2.3.1 Canada Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
5.3 Europe
      5.3.1 Europe Postpartum Hemorrhage Treatment Devices Market Revenue, by Country, 2013–2023 (USD Million)
      5.3.2 Germany
              5.3.2.1 Germany Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
      5.3.3 U.K.
              5.3.3.1 U.K. Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
      5.3.4 Rest of Europe
              5.3.4.1 Rest of Europe Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
5.4 Asia Pacific
      5.4.1 Asia Pacific Postpartum Hemorrhage Treatment Devices Market Revenue, by Country, 2013–2023 (USD Million)
      5.4.2 Japan
              5.4.2.1 Japan Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
      5.4.3 China
              5.4.3.1 China Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
      5.4.4 Rest of Asia Pacific
              5.4.4.1 Rest of Asia Pacific Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
5.5 Latin America (LATAM)
              5.5.1.1 Latin America Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
5.6 Middle East & North Africa (MENA)
              5.6.1.1 MENA Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
5.7 Rest of the World
      5.7.1 RoW Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
 
Chapter 6 Recommendations
 
Chapter 7 Company Profiles
7.1 3rd Stone Design, Inc.
      7.1.1 Company Overview
      7.1.2 Financial Overview
      7.1.3 Product Portfolio
      7.1.4 Business Strategies
      7.1.5 Recent Developments
7.2 Bactiguard AB
      7.2.1 Company Overview
      7.2.2 Financial Overview
      7.2.3 Product Portfolio
      7.2.4 Business Strategies
      7.2.5 Recent Developments
7.3 Cook Medical, Inc.
      7.3.1 Company Overview
      7.3.2 Financial Overview
      7.3.3 Product Portfolio
      7.3.4 Business Strategies
      7.3.5 Recent Developments
7.4 C. R. Bard, Inc.
      7.4.1 Company Overview
      7.4.2 Financial Overview
      7.4.3 Product Portfolio
      7.4.4 Business Strategies
      7.4.5 Recent Developments
7.5 Program for Appropriate Technology in Health (PATH)
      7.5.1 Company Overview
      7.5.2 Financial Overview
      7.5.3 Product Portfolio
      7.5.4 Business Strategies
      7.5.5 Recent Developments
7.6 Teleflex Incorporated
      7.6.1 Company Overview
      7.6.2 Financial Overview
      7.6.3 Product Portfolio
      7.6.4 Business Strategies
      7.6.5 Recent Developments
7.7 Utah Medical Products, Inc.
      7.7.1 Company Overview
      7.7.2 Financial Overview
      7.7.3 Product Portfolio
      7.7.4 Business Strategies
      7.7.5 Recent Developments
7.8 ZOEX NIASG
      7.8.1 Company Overview
      7.8.2 Financial Overview
      7.8.3 Product Portfolio
      7.8.4 Business Strategies
      7.8.5 Recent Developments

List of Figures
 
FIG. 1 Postpartum Hemorrhage Treatment Devices Market Segmentation
FIG. 2 Global Postpartum Hemorrhage Treatment Devices Market, by Product Type, 2014 (USD Million)
FIG. 3 Comparative Analysis: Global Postpartum Hemorrhage Treatment Devices Market, by Geography, 2014 & 2023 (Value %)
FIG. 4 Postpartum Hemorrhage Treatment Devices Market: Drivers & Restraints
FIG. 5 Porter’s Five Forces Analysis: Global Postpartum Hemorrhage Treatment Devices Market
FIG. 6 Market Attractiveness Analysis: Global Postpartum Hemorrhage Treatment Devices Market, by Geography
FIG. 7 Global NASG Market Revenue for Postpartum Hemorrhage Treatment, 2013–2023 (USD Million)
FIG. 8 Global Uniject Prefilled Injection System Market Revenue for Postpartum Hemorrhage Treatment, 2013–2023 (USD Million)
FIG. 9 Global Foley Catheters Market Revenue, 2013–2023 (USD Million)
FIG. 10 Global Condom Catheters Market Revenue, 2013–2023 (USD Million)
FIG. 11 Global Other Tamponades Market Revenue, 2013–2023 (USD Million)
FIG. 12 U.S. Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
FIG. 13 Canada Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
FIG. 14 Germany Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
FIG. 15 U.K. Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
FIG. 16 Rest of Europe Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
FIG. 17 Japan Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
FIG. 18 China Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
FIG. 19 Rest of Asia Pacific Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
FIG. 20 Latin America Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
FIG. 21 MENA Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
FIG. 22 RoW Postpartum Hemorrhage Treatment Devices Market Revenue, 2013–2023 (USD Million)
FIG. 23 Bactiguard AB: Annual Revenue, 2012–2014 (USD Million)
FIG. 24 C. R. Bard, Inc.: Annual Revenue, 2012–2014 (USD Million)
FIG. 25 PATH.: Annual Revenue, 2012–2014 (USD Million)
FIG. 26 PATH: Source of Funding, 2014 (%)
FIG. 27 Teleflex Incorporated: Annual Revenue, 2012–2014 (USD Million)
FIG. 28 Teleflex Incorporated: Segment Revenue, 2012–2014 (USD Million)
FIG. 29 Utah Medical Products, Inc.: Annual Revenue, 2012–2014 (USD Million)
FIG. 30 Utah Medical Products, Inc.: Segment Revenue, 2012–2014 (USD Million)

List of Tables
 
TABLE 1 Market Snapshot: Global Postpartum Hemorrhage Treatment Devices Market (2014 and 2023)
TABLE 2 Heat Map Analysis for Global Postpartum Hemorrhage Treatment Devices Market, by Key Market Players and Regional Presence
TABLE 3 Global Postpartum Hemorrhage Treatment Devices Market Revenue, by Product Type, 2013–2023 (USD Million)
TABLE 4 Comparative Analysis of UBT Devices, by Specifications
TABLE 5 Global Uterine Balloon Tamponade Market Revenue, by Product Type, 2013–2023 (USD Million)
TABLE 6 Global Postpartum Hemorrhage Treatment Devices Market Revenue, By Geography, 2013–2023 (USD Million)
TABLE 7 North America Postpartum Hemorrhage Treatment Devices Market Revenue, by Country, 2013–2023 (USD Million)
TABLE 8 Europe Postpartum Hemorrhage Treatment Devices Market Revenue, by Country, 2013–2023 (USD Million)
TABLE 9 Asia Pacific Postpartum Hemorrhage Treatment Devices Market Revenue, by Country, 2013–2023 (USD Million)

 
Postpartum hemorrhage (PPH) can be defined as blood loss in excess of 500 mL after vaginal delivery or more than 1,000 mL after cesarean delivery. If this amount of blood loss occurs within 24 hours of delivery, it is categorized as early or primary PPH. If such blood loss occurs after 24 hours of delivery, it is categorized as late or secondary PPH. This study provides market analysis for various medical devices that are used for the treatment of postpartum hemorrhage. The stakeholders of this market report comprise established medical device manufacturers, distributors, and new players who wish to enter the global postpartum hemorrhage treatment devices market.
 
This study provides a comprehensive analysis of the global postpartum hemorrhage treatment devices market and helps in recognizing several governing factors that impact the market both positively and negatively. Executive summary of the report captures comprehensive insights about every segment considered in this study. It includes a market snapshot offering an insight into the current scenario of the PPH treatment devices market in terms of current and future market size along with growth rate.
 
The market overview section provides thorough information on the trends in the usage of medical devices used for the treatment of PPH, such as drivers, restraints, and growth opportunities that presently regulate the dynamics of the overall market. Competitive analysis tools such as Porter’s Five Forces analysis and market attractiveness analysis have also been incorporated in this report to provide analysis about the level of competition within the postpartum hemorrhage treatment devices market. Furthermore, a section analyzing the regulatory framework and major events provides a bird’s-eye view on the major and upcoming events occurring in the global postpartum hemorrhage treatment devices market that could impact growth. Competitive intelligence tools such as heat map analysis have also been included in the market overview section of the report to deliver a broad spectrum of the overall scenario in the market at global level. Heat map analysis thus provided in this study is in context with major product manufacturers and distributors operating in the market; this would help new players to understand the key business models and geographical presence and identify the specific product lines of existing companies to establish a strong presence in the PPH treatment devices market.
 
The global postpartum hemorrhage treatment devices market has been segmented based on various products used across various geographies. The postpartum hemorrhage treatment devices market has been categorized into major products used for providing therapeutic treatment measures such as non-pneumatic anti-shock garment (NASG), the Uniject prefilled injection system, and uterine balloon tamponade. The uterine balloon tamponade segment has been further segmented into Foley catheters, condom catheters, and others (e.g. Bakri, Rusch, etc.). The market size for the period from 2013 to 2023 has been provided for each of the product categories mentioned above in terms of USD million. Along with the market size that was projected considering 2014 as the base year and 2013 as the historical year, the CAGR (%) of each market segment for the forecast period from 2015 to 2023 has also been provided.
 
Geographically, the PPH treatment devices market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World. North America has been further segmented into the U.S. and Canada; Europe into Germany, the U.K. and Rest of Europe; Asia Pacific into China, Japan, and Rest of Asia Pacific. The market revenue of PPH treatment devices for each geographical region for 2013 and 2023 along with forecast from 2015 to 2023 in respective regions in terms of USD million, has been explained in the geography section of the report.
 
This market study concludes with profiles of key players in the global postpartum hemorrhage treatment devices market. The report summarizes the companies in terms of overview, financial overview, product portfolio, business strategies, and recent developments. Key organizations profiled in this study include Cook Medical, Inc., Teleflex Incorporated, C. R. Bard, Inc., 3rd Stone Design, Inc., Bactiguard AB, Program for Appropriate Technology in Health (PATH), Utah Medical Products, Inc., and ZOEX NIASG.
The global postpartum hemorrhage treatment devices market is segmented into the following categories:
 
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Products
  • Non-pneumatic Anti-shock Garment (NASG)
  • Uniject Prefilled Injection System
  • Uterine Balloon Tamponade
    • Foley Catheters
    • Condom Catheters
    • Others
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America (LATAM)
  • Middle East & North Africa (MENA)
  • Rest of the World


 
 
Back To Top